• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在美国南部边境枢纽地区,SARS-CoV-2 的 Delta 变体迅速被 Omicron 亚变体取代。

Rapid Shift from SARS-CoV-2 Delta to Omicron Sub-Variants within a Dynamic Southern U.S. Borderplex.

机构信息

The Department of Biological Sciences, The University of Texas at El Paso, 500 W. University Ave, El Paso, TX 79968, USA.

Border Biomedical Research Center, The University of Texas at El Paso, 500 W. University Ave, El Paso, TX 79968, USA.

出版信息

Viruses. 2023 Feb 28;15(3):658. doi: 10.3390/v15030658.

DOI:10.3390/v15030658
PMID:36992367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10057517/
Abstract

COVID-19, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), remains an ongoing global health challenge. This study analyzed 3641 SARS-CoV-2 positive samples from the El Paso, Texas, community and hospitalized patients over 48 weeks from Fall 2021 to Summer 2022. The binational community along the U.S. southern border was predominantly SARS-CoV-2 Delta variant (B.1.617.2) positive for a 5-week period from September 2021 to January 2022 and quickly transitioned to the Omicron variant (B.1.1.529), which was first detected at the end of December 2021. Omicron replaced Delta as the predominant detectable variant in the community and was associated with a sharp increase in COVID-19 positivity rate, related hospitalizations, and newly reported cases. In this study, Omicron BA.1, BA.4, and BA.5 variants were overwhelmingly associated with S-gene dropout by qRT-PCR analysis unlike the Delta and Omicron BA.2 variants. The study reveals that a dominant variant, like Delta, can be rapidly replaced by a more transmissible variant, like Omicron, within a dynamic metropolitan border city, necessitating enhanced monitoring, readiness, and response from public health officials and healthcare workers.

摘要

新型冠状病毒病(COVID-19)由严重急性呼吸系统综合征冠状病毒 2 型(SARS-CoV-2)引起,仍然是全球持续存在的健康挑战。本研究分析了 2021 年秋季至 2022 年夏季期间来自德克萨斯州埃尔帕索社区和住院患者的 3641 份 SARS-CoV-2 阳性样本,时间长达 48 周。美国南部边境的这个跨国社区在 2021 年 9 月至 2022 年 1 月的 5 周内主要为 SARS-CoV-2 德尔塔变体(B.1.617.2)阳性,随后迅速过渡到奥密克戎变体(B.1.1.529),该变体于 2021 年 12 月底首次被发现。奥密克戎取代德尔塔成为社区中主要可检测的变体,与 COVID-19 阳性率、相关住院率和新报告病例的急剧增加相关。在这项研究中,与德尔塔和奥密克戎 BA.2 变体不同,qRT-PCR 分析显示奥密克戎 BA.1、BA.4 和 BA.5 变体与 S 基因脱落高度相关。该研究表明,像德尔塔这样的优势变体可以在动态大都市边境城市中被更具传染性的变体(如奥密克戎)迅速取代,这需要公共卫生官员和医护人员加强监测、准备和应对。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7754/10057517/9d06dc7434c3/viruses-15-00658-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7754/10057517/68dfd5f56867/viruses-15-00658-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7754/10057517/c0a436b7e24a/viruses-15-00658-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7754/10057517/06872522595e/viruses-15-00658-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7754/10057517/4369d965ca28/viruses-15-00658-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7754/10057517/aaf56a792678/viruses-15-00658-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7754/10057517/9d06dc7434c3/viruses-15-00658-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7754/10057517/68dfd5f56867/viruses-15-00658-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7754/10057517/c0a436b7e24a/viruses-15-00658-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7754/10057517/06872522595e/viruses-15-00658-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7754/10057517/4369d965ca28/viruses-15-00658-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7754/10057517/aaf56a792678/viruses-15-00658-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7754/10057517/9d06dc7434c3/viruses-15-00658-g006.jpg

相似文献

1
Rapid Shift from SARS-CoV-2 Delta to Omicron Sub-Variants within a Dynamic Southern U.S. Borderplex.在美国南部边境枢纽地区,SARS-CoV-2 的 Delta 变体迅速被 Omicron 亚变体取代。
Viruses. 2023 Feb 28;15(3):658. doi: 10.3390/v15030658.
2
Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.美国亚利桑那州公共临床检测、医院和社区污水的基线测序监测显示,SARS-CoV-2 关注的奥密克戎变异株迅速出现。
mBio. 2023 Feb 28;14(1):e0310122. doi: 10.1128/mbio.03101-22. Epub 2023 Jan 9.
3
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间,加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局,期间 B.1.617.2(德尔塔)和 B.1.1.529(奥密克戎)变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
4
Clinical outcomes and phylogenetic analysis in reflection with three predominant clades of SARS-CoV-2 variants.与 SARS-CoV-2 三种主要变异株相关的临床结果和系统进化分析。
Eur J Clin Invest. 2023 Sep;53(9):e14004. doi: 10.1111/eci.14004. Epub 2023 May 2.
5
Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022.SARS-CoV-2 变体的基因组监测:Delta(B.1.617.2)和奥密克戎(B.1.1.529)变体占主导地位-美国,2021 年 6 月-2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):206-211. doi: 10.15585/mmwr.mm7106a4.
6
Genomic profile of SARS-CoV-2 Omicron variant and its correlation with disease severity in Rajasthan.拉贾斯坦邦严重急性呼吸综合征冠状病毒2型奥密克戎变种的基因组概况及其与疾病严重程度的相关性
Front Med (Lausanne). 2022 Sep 23;9:888408. doi: 10.3389/fmed.2022.888408. eCollection 2022.
7
SARS-CoV-2 wastewater monitoring using a novel PCR-based method rapidly captured the Delta-to-Omicron ΒΑ.1 transition patterns in the absence of conventional surveillance evidence.利用一种新型基于 PCR 的方法对 SARS-CoV-2 废水进行监测,在缺乏常规监测证据的情况下,迅速捕捉到了德尔塔变异株向奥密克戎 ΒΑ.1 变异株的转变模式。
Sci Total Environ. 2022 Oct 20;844:156932. doi: 10.1016/j.scitotenv.2022.156932. Epub 2022 Jun 24.
8
Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.疾病严重程度和医疗保健利用趋势在奥密克戎变异株早期与之前 SARS-CoV-2 高传播期相比-美国,2020 年 12 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):146-152. doi: 10.15585/mmwr.mm7104e4.
9
Genomic surveillance of SARS-CoV-2 in COVID-19 vaccinated healthcare workers in Lebanon.黎巴嫩 COVID-19 疫苗接种医护人员中 SARS-CoV-2 的基因组监测。
BMC Med Genomics. 2023 Jan 27;16(1):14. doi: 10.1186/s12920-023-01443-9.
10
Airborne virus shedding of the alpha, delta, omicron SARS-CoV-2 variants and influenza virus in hospitalized patients.住院患者中阿尔法、德尔塔、奥密克戎SARS-CoV-2变种及流感病毒的空气传播病毒排放情况。
J Med Virol. 2023 Apr;95(4):e28748. doi: 10.1002/jmv.28748.

引用本文的文献

1
From Emergence to Evolution: Dynamics of the SARS-CoV-2 Omicron Variant in Florida.从出现到进化:佛罗里达州新冠病毒奥密克戎变种的动态变化
Pathogens. 2024 Dec 12;13(12):1095. doi: 10.3390/pathogens13121095.
2
Wastewater Surveillance of SARS-CoV-2 in Zambia: An Early Warning Tool.赞比亚的 SARS-CoV-2 污水监测:预警工具。
Int J Mol Sci. 2024 Aug 14;25(16):8839. doi: 10.3390/ijms25168839.
3
Detection and Characterisation of SARS-CoV-2 in Eastern Province of Zambia: A Retrospective Genomic Surveillance Study.赞比亚东部省 SARS-CoV-2 的检测和特征分析:一项回顾性基因组监测研究。

本文引用的文献

1
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents.啮齿动物中新型冠状病毒奥密克戎BA.4和BA.5毒株的特征分析
Nature. 2022 Dec;612(7940):540-545. doi: 10.1038/s41586-022-05482-7. Epub 2022 Nov 2.
2
Comparison of Rapid Antigen Tests' Performance Between Delta and Omicron Variants of SARS-CoV-2 : A Secondary Analysis From a Serial Home Self-testing Study.德尔塔和奥密克戎变异株 SARS-CoV-2 的快速抗原检测性能比较:一项连续家庭自测研究的二次分析。
Ann Intern Med. 2022 Dec;175(12):1685-1692. doi: 10.7326/M22-0760. Epub 2022 Oct 11.
3
Validation of reduced S-gene target performance and failure for rapid surveillance of SARS-CoV-2 variants.
Int J Mol Sci. 2024 Jun 7;25(12):6338. doi: 10.3390/ijms25126338.
4
Sensitive detection of SARS-CoV-2 main protease 3CL with an engineered ribonuclease zymogen.用工程化核酶原对 SARS-CoV-2 主蛋白酶 3CL 进行灵敏检测。
Protein Sci. 2024 Apr;33(4):e4916. doi: 10.1002/pro.4916.
5
Investigating the rise of Omicron variant through genomic surveillance of SARS-CoV-2 infections in a highly vaccinated university population.通过对高度接种疫苗的大学人群中新冠病毒感染进行基因组监测来调查奥密克戎变异株的出现情况。
Microb Genom. 2024 Feb;10(2). doi: 10.1099/mgen.0.001194.
6
Validation of the VirCapSeq-VERT system for differential diagnosis, detection, and surveillance of viral infections.验证 VirCapSeq-VERT 系统用于病毒感染的鉴别诊断、检测和监测。
J Clin Microbiol. 2024 Jan 17;62(1):e0061223. doi: 10.1128/jcm.00612-23. Epub 2023 Dec 14.
用于 SARS-CoV-2 变异快速监测的 S 基因靶标性能降低和失败的验证。
PLoS One. 2022 Oct 3;17(10):e0275150. doi: 10.1371/journal.pone.0275150. eCollection 2022.
4
Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark.丹麦关注的 SARS-CoV-2 奥密克戎变体 BA.1 和 BA.2 亚变体的家庭传播。
Nat Commun. 2022 Sep 30;13(1):5760. doi: 10.1038/s41467-022-33498-0.
5
The outbreak of SARS-CoV-2 Omicron lineages, immune escape, and vaccine effectivity.奥密克戎变异株引发的 SARS-CoV-2 疫情、免疫逃逸和疫苗效力。
J Med Virol. 2023 Jan;95(1):e28138. doi: 10.1002/jmv.28138. Epub 2022 Sep 21.
6
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.奥密克戎亚系的起源、病毒学特征、免疫逃逸与干预。
Signal Transduct Target Ther. 2022 Jul 19;7(1):241. doi: 10.1038/s41392-022-01105-9.
7
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.奥密克戎 BA.4 和 BA.5 对疫苗和 BA.1 血清的抗体逃逸。
Cell. 2022 Jul 7;185(14):2422-2433.e13. doi: 10.1016/j.cell.2022.06.005. Epub 2022 Jun 9.
8
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.BA.2.12.1、BA.4 和 BA.5 逃避奥密克戎感染诱导的抗体。
Nature. 2022 Aug;608(7923):593-602. doi: 10.1038/s41586-022-04980-y. Epub 2022 Jun 17.
9
Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS-CoV-2 variants.精准健康诊断和监测网络使用 S 基因靶标失败 (SGTF) 与测序技术相结合,来追踪新兴的 SARS-CoV-2 变异株。
Immun Inflamm Dis. 2022 Jun;10(6):e634. doi: 10.1002/iid3.634.
10
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.SARS-CoV-2 奥密克戎 BA.2 刺突的病毒学特征。
Cell. 2022 Jun 9;185(12):2103-2115.e19. doi: 10.1016/j.cell.2022.04.035. Epub 2022 May 2.